Risk Factors for Therapeutic Intervention of Remdesivir in Mild to Moderate COVID-19—A Single-Center Retrospective Study of the COVID-19 Fourth Pandemic Period in Wakayama, Japan

Risk Factors for Therapeutic Intervention of Remdesivir in Mild to Moderate COVID-19—A Single-Center Retrospective Study of the COVID-19 Fourth Pandemic Period in Wakayama, Japan

<i>Background and Objectives:</i> The incidence of coronavirus disease 2019 (COVID-19) has increased in Wakayama, Japan, due to the spread of the highly infectious B.1.1.7 variant. Before this event, the medical systems were almost unaffected. We aimed to assess the clinical characterist...

Full description

Bibliographic Details
Main Authors: Shinobu Tamura, Takahiro Kaki, Mayako Niwa, Yukiko Yamano, Shintaro Kawai, Yusuke Yamashita, Harumi Tanaka, Yoshinobu Saito, Yoshinori Kajimoto, Yusuke Koizumi, Hiroki Yamaue, Naoyuki Nakao, Takako Nojiri, Masaya Hironishi
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Medicina
Subjects:
COVID-19
B.1.1.7 variant
hospitalization
remdesivir
headache
Online Access:https://www.mdpi.com/1648-9144/58/1/118

Internet

https://www.mdpi.com/1648-9144/58/1/118

Similar Items